Bio Pharma Dive

JULY 14, 2021

Formed around research from the Broad Institute's David Liu and Andrew Anzalone, Prime has attracted significant funding from a wide range of high-profile biotech backers.

Gene Editing 317

Gene Editing Medicine Gene Research 317

Bio Pharma Dive

OCTOBER 2, 2020

Under his leadership, Merck developed a once overlooked cancer drug into Keytruda, now a top-selling medicine and foundational treatment for more than a dozen types of tumors.

Research 328

Research Medicine Development Drugs 328

Bio Pharma Dive

OCTOBER 11, 2022

Launched last year to change how drugs for brain diseases are made, the biotech has now raised about $650 million to build a pipeline that includes two clinical-stage medicines.

Research 331

Research Medicine Drugs 331

Bio Pharma Dive

MAY 19, 2023

The biotech, best known for its vaccine research, said its clinical trial is the first to report results of a messenger RNA therapeutic designed for intracellular protein replacement.

RNA 305

RNA Medicine Clinical Trials Clinical Trials 305

Pharmaceutical Technology

MAY 9, 2024

A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.

Medicine 130

Medicine Development Research 130

Pharmaceutical Technology

OCTOBER 2, 2023

The Physiology and Medicine Prize has gone to two researchers whose work laid the foundation for Pfizer and Moderna’s Covid-19 vaccines.

Vaccine 257

Vaccine Vaccination Research Medicine 257

Pharmaceutical Technology

FEBRUARY 6, 2023

Researchers at the Feinstein Institutes for Medical Research have discovered a new protein that can be a potential therapeutic target for lethal sepsis. Led by Feinstein Institutes researcher Haichao Wang, the new study focuses on detecting protein mediators that might contribute to uncontrolled immune responses to lethal infections.

Protein 263

Protein Research Antibody Immune Response 263

Bio Pharma Dive

FEBRUARY 28, 2023

An alliance with the startup brings Vertex an RNA-based medicine for the disease, adding to a portfolio that already includes a gene editing treatment.

Gene Editing 279

Gene Editing RNA Gene Research 279

Bio Pharma Dive

OCTOBER 19, 2023

The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.

Research 290

Research Medicine 290

Pharmaceutical Technology

JULY 7, 2022

But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. A new frontier in cancer research. It is certainly a pivotal moment for the cell and gene industry, with the next decade of R&D and clinical trials expected to transform the future of medicine.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

Bio Pharma Dive

SEPTEMBER 8, 2021

The company, which focuses on self-replicating RNA, comes equipped with $40 million from Apple Tree Partners and a stamp of approval from the former research head at Biogen.

RNA 272

RNA Medicine Research 272

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 10, 2024

By focusing on clinical excellence, comprehensive education, and cutting-edge research, the Arya Vaidya Pharmacy Research Foundation (AVPRF) based in Coimbatore is ensuring that ayurvedic practices are validated, credible, and relevant for future generations.

Medicine 207

Medicine Pharmacy Research Clinical Trials 207

Bio Pharma Dive

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Research 238

Research Medicine Drugs 238

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 17, 2024

Biology is opening up new frontiers in medicine. We are witnessing a revolution in healthcare, driven by advances in genetics, Omics, RNA and CRISPR gene-editing technology, to deliver precision and personalised medicine, said Kiran Mazumdar-Shaw, executive chairperson, Biocon and Biocon Biologics.

Genetic Disease 185

Genetic Disease Genetics Gene Editing Medicine 185

Pharmaceutical Technology

FEBRUARY 3, 2023

The field of genomic medicine has reached a true turning point. Researchers have relentlessly worked through the barriers to create lifechanging treatments for patients in need. “As For example, researchers have developed a two-plasmid cotransfection system. CEVEC became part of Cytiva in October 2022.

Genome 244

Genome Genomics Medicine Gene Therapy 244

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. The company stated that bringing together advanced formulation discovery and generative AI will help in designing new mRNA medicines with optimal safety and performance.

Research 246

Research Gene Therapy Gene Scientist 246

Bio Pharma Dive

DECEMBER 1, 2022

The regulatory OK, a milestone for microbiome-based drug research, is for a medicine from Ferring Pharma that treats a recurrent type of gut infection.

FDA Approval 358

FDA Approval Medicine Drugs Research 358

Bio Pharma Dive

NOVEMBER 9, 2021

The biotech is researching how to make medicines from transfer RNA molecules. Encouraged by Moderna's success, Flagship Pioneering has been busy creating startups like Alltrna, which launched Tuesday.

RNA 359

RNA Medicine Drugs Research 359

Bio Pharma Dive

JUNE 26, 2021

Results published in The New England Journal of Medicine offer the first clinical evidence that CRISPR gene editing inside the body can be safe and effective, a culmination of years of scientific research.

Gene Editing 363

Gene Editing Gene Medicine Research 363

Bio Pharma Dive

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies 246

Pharma Companies Research Medicine Drugs 246

Bio Pharma Dive

AUGUST 16, 2023

The struggling biotech also plans to offload other cell therapy assets, including a multiple myeloma therapy, and focus exclusively on gene editing medicines.

Gene Editing 246

Gene Editing Gene Research Medicine 246

Bio Pharma Dive

NOVEMBER 21, 2024

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to overcome the looming loss of exclusivity for some of its top-selling medicines.

Scientist 319

Scientist Medicine Research 319

Bio Pharma Dive

AUGUST 17, 2021

Lilly Bio-Medicines will be split into separate neuroscience and immunology groups, while the Loxo cancer research division will merge with Lilly Oncology.

Medicine 331

Medicine Drugs Research 331

Pharmaceutical Technology

OCTOBER 15, 2024

digital twins can be used to progress healthcare, drug development, and research by enabling the delivery of personalised medicine.

Medicine 130

Medicine Development Drugs Research 130

Bio Pharma Dive

NOVEMBER 29, 2022

In this continuing series, BioPharma Dive examines new areas of biotech investment and startup activity, such as next-generation RNA medicines, TYK2 inhibitors and in vivo CAR-T.

In-Vivo 240

In-Vivo RNA Research Medicine 240

Pharmaceutical Technology

MAY 12, 2023

The research team has designed four bacterial viruses which use CRISPR technology to kill the unwanted bacteria precisely. The division of infectious diseases at Weill Cornell Medicine carried out the work in collaboration with JAFRAL and JMI Laboratories.

Development 246

Development Bacteria Research Gene Editing 246

Bio Pharma Dive

NOVEMBER 17, 2021

Chroma Medicine's launch is the latest step in a decadeslong quest by drugmakers to capitalize on research into epigenetics, a way of controlling gene expression without altering DNA.

Gene Expression 325

Gene Expression DNA Gene Medicine 325

Bio Pharma Dive

MARCH 1, 2023

At a time when many startups have struggled to gain cash, the biotech has raised another $135 million to back its research, a new twist on genetic medicine.

Genetics 321

Genetics Medicine Research 321

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 5, 2023

In order to create a pool of talented health research professionals in the country, the Indian Council of Medical Research (ICMR) has introduced a training course on “Harnessing the Power of Immunology in Medicine: Tools, Translation and Therapy”.

Research 182

Research Medicine Clinical Trials Clinical Trials 182

Bio Pharma Dive

JANUARY 4, 2024

The CRISPR specialist joins some of its genetic medicine peers in trimming staff, announcing an “organizational streamlining” to focus resources on prioritiy drug programs.

Genetics 195

Genetics Research Medicine Drugs 195

Pharmaceutical Technology

MAY 14, 2024

Dandelion Health’s database can be used as a tool for sponsors to decide which indications to next investigate GLP1-RAs in.

Medicine 147

Medicine Research 147

Bio Pharma Dive

SEPTEMBER 12, 2024

Spun out of research at Nationwide Children’s Hospital, Vironexis claims it will be the first company to start a study testing a cancer drug delivered via the adeno-associated viruses commonly used in genetic medicines.

Gene Therapy 290

Gene Therapy Gene Genetics Trials 290

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 15, 2022

ABAC Therapeutics, together with the artificial intelligence (AI) company Peptris and the Foundation for Neglected Disease Research (FNDR), with scientific support from Medicines for Malaria Venture (MMV), has collaborated to optimize a new chemical structure that has shown effectiveness against gram-negative bacteria, the current threat to public (..)

Bacteria 188

Bacteria Research Medicine Drugs 188

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2023

The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.

Medicine 184

Medicine Development Pharma Companies Clinical Trials 184

Rethinking Clinical Trials

FEBRUARY 28, 2024

In this Friday’s PCT Grand Rounds, Joseph Doyle of the Massachusetts Institute of Technology (MIT) will present “Effect of an Intensive Food-as-Medicine Program on Health and Healthcare Use: Evidence From a Randomized Clinical Trial.” ” The Grand Rounds session will be held on Friday, March 1, 2024, at 1:00 pm eastern.

Medicine 147

Medicine Trials Clinical Trials Clinical Trials 147

Bio Pharma Dive

APRIL 1, 2022

Taysha Gene Therapies is narrowing its research efforts and cutting around 35% of its workforce, the latest in a series of layoffs announced by makers of genetic medicines.

Gene Therapy 289

Gene Therapy Gene Development Genetics 289

Bio Pharma Dive

FEBRUARY 12, 2021

Lysosomal storage disorders, diseases of cellular metabolism gone wrong, are the focus of a fast-expanding lineup of experimental genetic medicines, a research boom that recalls biotech's roots.

Gene Therapy 290

Gene Therapy Gene Genetics Medicine 290